These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 19420982)
1. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways. Hurst JH; Hooks SB Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982 [TBL] [Abstract][Full Text] [Related]
2. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242 [TBL] [Abstract][Full Text] [Related]
3. Regulator of G-protein signalling expression and function in ovarian cancer cell lines. Hurst JH; Mendpara N; Hooks SB Cell Mol Biol Lett; 2009; 14(1):153-74. PubMed ID: 18979070 [TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells. Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer. Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595 [TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells. Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008 [TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line. Zhang Z; Liu Z; Meier KE Am J Physiol Cell Physiol; 2006 Nov; 291(5):C1089-98. PubMed ID: 16760261 [TBL] [Abstract][Full Text] [Related]
8. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Chen M; Towers LN; O'Connor KL Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233 [TBL] [Abstract][Full Text] [Related]
10. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells. Sugimoto N; Takuwa N; Yoshioka K; Takuwa Y Exp Cell Res; 2006 Jun; 312(10):1899-908. PubMed ID: 16564043 [TBL] [Abstract][Full Text] [Related]
11. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts. Olianas MC; Dedoni S; Onali P Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927 [TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid stimulates prostaglandin E2 production in cultured stromal endometrial cells through LPA1 receptor. Woclawek-Potocka I; Kondraciuk K; Skarzynski DJ Exp Biol Med (Maywood); 2009 Aug; 234(8):986-93. PubMed ID: 19491366 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca cells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway? Budnik LT; Brunswig-Spickenheier B; Mukhopadhyay AK Mol Endocrinol; 2003 Aug; 17(8):1593-606. PubMed ID: 12730329 [TBL] [Abstract][Full Text] [Related]
14. Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by lysophosphatidic acid, sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptor. Callihan P; Ali MW; Salazar H; Quach N; Wu X; Stice SL; Hooks SB ASN Neuro; 2014; 6(6):. PubMed ID: 25424429 [TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway. Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791 [TBL] [Abstract][Full Text] [Related]
16. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252 [TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells. Saunders JA; Rogers LC; Klomsiri C; Poole LB; Daniel LW Free Radic Biol Med; 2010 Dec; 49(12):2058-67. PubMed ID: 20934509 [TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786 [TBL] [Abstract][Full Text] [Related]
19. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq. Kim J; Keys JR; Eckhart AD Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475 [TBL] [Abstract][Full Text] [Related]
20. Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes. Sato K; Horiuchi Y; Jin Y; Malchinkhuu E; Komachi M; Kondo T; Okajima F J Neurochem; 2011 Apr; 117(1):164-74. PubMed ID: 21244430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]